B
Bionik Labaratories
Innovative medical device and robotics company
About Bionik Labaratories
Bionik Laboratories, founded in 2010 by Michal Prywata and Thiago Caires, is a publicly traded healthcare company focused on neurorehabilitation technology. The company's strategic direction was significantly shaped by its 2016 acquisition of Interactive Motion Technologies (IMT), a 1998 MIT spin-off founded by pioneers in robotics engineering, Dr. Hermano I. Krebs and Dr. Neville Hogan. This acquisition integrated IMT's established product line and commercial presence into Bionik's portfolio, with Dr. Krebs joining as Chief Science Officer to continue guiding the scientific development rooted in his MIT research.
The company's business model involves direct sales and distribution agreements for its robotic devices to hospitals and rehabilitation clinics worldwide, including partnerships in Asia and across the U.S. with major healthcare providers like Lifepoint Health. Bionik also operates its own neuro-recovery centers, providing direct rehabilitation services to patients, which serves as both a revenue stream and a framework for showcasing its technology's effectiveness. This dual approach allows the company to gather extensive, anonymized patient data through its InMotion Connect platform, a cloud-based analytics tool that helps clinicians monitor progress and refine therapy protocols.
Bionik's core offerings are the InMotion robotic systems, designed for upper-extremity therapy for patients recovering from strokes, spinal cord injuries, and other neurological conditions. The product suite, including the InMotion ARM, HAND, and WRIST, utilizes an "assist-as-needed" therapeutic approach, where the robots provide intelligent, adaptive assistance to help patients complete tasks, aiming to remap neural pathways and restore motor control. These devices also function as diagnostic tools, providing objective data on a patient's impairment and recovery progress. Concurrently, Bionik is developing its ARKE lower-body exoskeleton technology, initially for clinical rehabilitation with a long-term vision to create more accessible, consumer-focused versions for in-home use.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2009
- Headquarters
- Watertown, United States
- Listing
- IPO 2019
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
DMZ
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bionik Labaratories on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bionik Labaratories on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.